HFD-fed mice developed severe obesity (+71% in body weight), hyperinsulinemia (+2.9-fold in nonfasted serum insulin), and hypertriglyceridemia (+53% in nonfasted serum triacylglyceride, TAG) but did not display basal hyperglycemia (no significant changes in nonfasted blood glucose) (Supplemental Figure 7). The gene discussed is INS; the disease is obesity disorder.